Breast Cancer

Imaging Product Improves Detection Of Metastatic Disease

Published in Women's Health Weekly, January 10th, 2002

Immunomedics, Inc., announced that its approved diagnostic imaging product for colorectal cancer, CEA-Scan (arcitumomab), was the subject of a presentation at the 24th Annual San Antonio Breast Cancer Symposium in December 2001.

The paper was authored by Dr. Joshua Rettig of the Arlington Cancer Center in Arlington, Texas.

In patients with suspected spread, or metastasis, of breast cancer, it is important to confirm the presence and location of these distant sites of disease. The study reported by Dr. Rettig involved 14 patients, 13 women and 1 man, with confirmed breast cancer and whose computed tomography (CT) findings did not show certain...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry